16 October 2013 | News | By BioSpectrum Bureau
Singapore: Shanghai Fosun Pharmaceutical has purchased a 50 percent stake in Guangzhou Nanyang Tumour Hospital.
Fosun Pharma is on the spree of developing medical services and has purchased hospitals in China and abroad. It is also planning to building an international medical aircraft carrier.
According to Fosun Pharma, high-level tumour medical services and extensive international influence of Guangzhou Nanyang Tumour Hospital could be helpful for its entrance into the field of international tumour medical treatment from a higher starting point.
Guangzhou Nanyang Tumour Hospital is an international authoritative tumour specialized hospital.